ACA
RPRX icon

American Capital Advisory’s Royalty Pharma RPRX Stock Holding History

American Capital Advisory’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.8K Hold
516
– – 0.01% 269
2025
Q4 		$19.9K Sell
516
-197
-28% -$7.51K 0.01% 281
2025
Q3 		$25.2K Sell
713
-3
-0.4% -$109 0.01% 248
2025
Q2 		$25.8K Buy
716
+12
+2% +$398 0.01% 240
2025
Q1 		$21.9K Buy
704
+4
+0.6% +$127 0.01% 255
2024
Q4 		$17.9K Hold
700
– – 0.01% 262
2024
Q3 		$19.8K Sell
700
-200
-22% -$5.54K 0.01% 250
2024
Q2 		$25.3K Sell
900
-100
-10% -$2.77K 0.02% 201
2024
Q1 		$36K Buy
1,000
+100
+11% +$2.95K 0.03% 162
2023
Q4 		$25.3K Buy
+900
New +$24.7K 0.02% 201

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return